365 related articles for article (PubMed ID: 27104502)
21. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
22. Temperature- and moisture-induced crystallization of amorphous lactose in composite particles with sodium alginate prepared by spray-drying.
Takeuchi H; Yasuji T; Yamamoto H; Kawashima Y
Pharm Dev Technol; 2000; 5(3):355-63. PubMed ID: 10934735
[TBL] [Abstract][Full Text] [Related]
23. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
24. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems.
Wu W; Wang Y; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2019 Mar; 16(3):1294-1304. PubMed ID: 30624075
[TBL] [Abstract][Full Text] [Related]
25. Influence of Drug Load on the Printability and Solid-State Properties of 3D-Printed Naproxen-Based Amorphous Solid Dispersion.
Kissi EO; Nilsson R; Nogueira LP; Larsson A; Tho I
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361646
[TBL] [Abstract][Full Text] [Related]
26. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation.
Allesø M; Chieng N; Rehder S; Rantanen J; Rades T; Aaltonen J
J Control Release; 2009 May; 136(1):45-53. PubMed ID: 19331842
[TBL] [Abstract][Full Text] [Related]
27. Thermal insight of mechanically activated bile acid powders.
Ito T; Byrn S; Chen X; Carvajal MT
Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
[TBL] [Abstract][Full Text] [Related]
28. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
29. Effects of Mono-, Di-, and Tri-Saccharides on the Stability and Crystallization of Amorphous Sucrose.
Thorat AA; Forny L; Meunier V; Taylor LS; Mauer LJ
J Food Sci; 2018 Nov; 83(11):2827-2839. PubMed ID: 30320406
[TBL] [Abstract][Full Text] [Related]
30. Correlation between molecular dynamics and physical stability of two milled anhydrous sugars: Lactose and sucrose.
Smith G; Hussain A; Bukhari NI; Ermolina I
Int J Pharm; 2018 Nov; 551(1-2):184-194. PubMed ID: 30223078
[TBL] [Abstract][Full Text] [Related]
31. Confinement of Amorphous Lactose in Pores Formed Upon Co-Spray Drying With Nanoparticles.
Hellrup J; Mahlin D
J Pharm Sci; 2017 Jan; 106(1):322-330. PubMed ID: 27836110
[TBL] [Abstract][Full Text] [Related]
32. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
33. Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol.
Schammé B; Couvrat N; Malpeli P; Dudognon E; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2016 Feb; 499(1-2):67-73. PubMed ID: 26707413
[TBL] [Abstract][Full Text] [Related]
34. Exploring the solid-form landscape of pharmaceutical hydrates: transformation pathways of the sodium naproxen anhydrate-hydrate system.
Raijada D; Bond AD; Larsen FH; Cornett C; Qu H; Rantanen J
Pharm Res; 2013 Jan; 30(1):280-9. PubMed ID: 22996567
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
[TBL] [Abstract][Full Text] [Related]
36. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
Kumar S; Burgess DJ
Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
[TBL] [Abstract][Full Text] [Related]
37. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Recrystallization of Amorphous Lactose in Nanocomposites Formed by Spray-Drying.
Hellrup J; Alderborn G; Mahlin D
J Pharm Sci; 2015 Nov; 104(11):3760-3769. PubMed ID: 26182904
[TBL] [Abstract][Full Text] [Related]
39. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
[TBL] [Abstract][Full Text] [Related]
40. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
